Search Results - "Pandya, G."

New discoveries in the pathogenesis and classification of vitiligo by Rodrigues, Michelle, MBBS(Hons), FACD, Ezzedine, Khaled, MD, PhD, Hamzavi, Iltefat, MD, Pandya, Amit G., MD, Harris, John E., MD, PhD

“…Vitiligo is a common autoimmune disease that progressively destroys melanocytes in the skin, resulting in the appearance of patchy depigmentation. This…”
Get full text

Oral Tranexamic Acid for the Treatment of Melasma: A Review by Bala, Harini R, Lee, Senhong, Wong, Celestine, Pandya, Amit.G, Rodrigues, Michelle

“…BACKGROUNDMelasma is a common acquired disorder of hyperpigmentation that commonly affects those with skin of color. Tranexamic acid (TXA) is a novel treatment…”
Get full text

Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo by Rosmarin, David, Passeron, Thierry, Pandya, Amit G., Grimes, Pearl, Harris, John E., Desai, Seemal R., Lebwohl, Mark, Ruer-Mulard, Mireille, Seneschal, Julien, Wolkerstorfer, Albert, Kornacki, Deanna, Sun, Kang, Butler, Kathleen, Ezzedine, Khaled

“…In two phase 3, double-blind, placebo-controlled trials, the Janus kinase inhibitor ruxolitinib showed superiority to vehicle control in facial repigmentation…”
Get full text

Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo by Richmond, Jillian M, Strassner, James P, Zapata, Jr, Lucio, Garg, Madhuri, Riding, Rebecca L, Refat, Maggi A, Fan, Xueli, Azzolino, Vincent, Tovar-Garza, Andrea, Tsurushita, Naoya, Pandya, Amit G, Tso, J Yun, Harris, John E

“…Vitiligo is an autoimmune disease of the skin mediated by CD8 T cells that kill melanocytes and create white spots. Skin lesions in vitiligo frequently return…”
Get more information

Current and emerging treatments for vitiligo by Rodrigues, Michelle, MBBS(Hons), FACD, Ezzedine, Khaled, MD, PhD, Hamzavi, Iltefat, MD, Pandya, Amit G., MD, Harris, John E., MD, PhD

“…Clinicians should be aware that vitiligo is not merely a cosmetic disease and that there are safe and effective treatments available for vitiligo. It is…”
Get full text

Increasing racial and ethnic diversity in dermatology: A call to action by Pandya, Amit G., MD, FAAD, Alexis, Andrew F., MD, MPH, FAAD, Berger, Timothy G., MD, FAAD, Wintroub, Bruce U., MD, FAAD

Get full text

Platelets stored at 4°C contribute to superior clot properties compared to current standard‐of‐care through fibrin‐crosslinking by Nair, Prajeeda M., Pandya, Shaunak G., Dallo, Shatha F., Reddoch, Kristin M., Montgomery, Robbie K., Pidcoke, Heather F., Cap, Andrew P., Ramasubramanian, Anand K.

“…Summary Currently, platelets for transfusion are stored at room temperature (RT) for 5–7 days with gentle agitation, but this is less than optimal because of…”
Get full text

Vitiligo is not a cosmetic disease by Ezzedine, Khaled, MD, PhD, Sheth, Vaneeta, MD, Rodrigues, Michelle, MBBS (Hons), FACD, Eleftheriadou, Viktoria, MD, PhD, Harris, John E., MD, PhD, Hamzavi, Iltefat H., MD, Pandya, Amit G., MD

Get full text

The Vitiligo Working Group recommendations for narrowband ultraviolet B light phototherapy treatment of vitiligo by Mohammad, Tasneem F., MD, Al-Jamal, Mohammed, MD, Hamzavi, Iltefat H., MD, Harris, John E., MD, PhD, Leone, Giovanni, MD, Cabrera, Raúl, MD, Lim, Henry W., MD, Pandya, Amit G., MD, Esmat, Samia M., MD

“…Background Treatment of vitiligo with narrowband ultraviolet B light (NBUVB) is an important component of the current standard of care. However, there are no…”
Get full text

Comorbidity Burden Among Patients with Vitiligo in the United States: A Large-Scale Retrospective Claims Database Analysis by Ezzedine, Khaled, Soliman, Ahmed M., Li, Chao, Camp, Heidi S., Pandya, Amit G.

“…Introduction Vitiligo is often associated with comorbid conditions that may increase economic burden and affect patients’ health-related quality of life. No…”
Get full text

Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method by Pandya, Amit G., MD, Hynan, Linda S., PhD, Bhore, Rafia, PhD, Riley, Fransell Copeland, MS, Guevara, Ian L., MD, Grimes, Pearl, MD, Nordlund, James J., MD, Rendon, Marta, MD, Taylor, Susan, MD, Gottschalk, Ronald W., MD, FRCPC, Agim, Nnenna G., MD, Ortonne, Jean-Paul, MD

“…Background The Melasma Area and Severity Index (MASI), the most commonly used outcome measure for melasma, has not been validated. Objective We sought to…”
Get full text

Confetti-like depigmentation: A potential sign of rapidly progressing vitiligo by Sosa, Juan Jesús, BS, Currimbhoy, Sharif D., MD, Ukoha, Uzoamaka, BS, Sirignano, Samantha, BS, O'Leary, Ryan, MD, Vandergriff, Travis, MD, Hynan, Linda S., PhD, Pandya, Amit G., MD

“…Background Confetti-like depigmentation was noted in patients reporting recent worsening of vitiligo. Objective We sought to determine if confetti-like…”
Get full text

Assessing Participants’ Experiences with Vitiligo from Patient Interviews by Pandya, Amit G., Amoloja, Theresa, Bibeau, Kristen, DiBenedetti, Dana, Kosa, Katherine, Butler, Kathleen, Kornacki, Deanna, Ezzedine, Khaled

“…Introduction Vitiligo is an autoimmune disease, causing skin depigmentation. Individuals with vitiligo incur substantial psychosocial burden and have expressed…”
Get full text

Presentations, Signs of Activity, and Differential Diagnosis of Vitiligo by Goh, Boon-Kee, MD, Pandya, Amit G., MD

“…Vitiligo has a variety of presentations, including focal, acrofacial, segmental, and generalized forms. Thorough knowledge of these presentations is important…”
Get full text

Diagnosed Prevalence and Incidence of Vitiligo in the United States: Analysis of Employer-Sponsored Insurance Claims by Ray, Markqayne, Gandhi, Kavita, Maughn, Keshia, Pandya, Amit G.

Get full text

Vitiligo International Task force for an Agreed List of core data (VITAL): study protocol of a vitiligo core outcome set (COS) and contextual factors for clinical trials, registries, and clinical practice by van Geel, Nanja, Hamzavi, Iltefat H, Pandya, Amit G, Wolkerstorfer, Albert, Seneschal, Julien, Garg, Amit, Spuls, Phyllis, Terwee, Caroline B, Mallett, Sue, Speeckaert, Reinhart, Meurant, Jean Marie, Eleftheriadou, Viktoria, Ezzedine, Khaled

“…Abstract Background There is a lack of consensus related to the collection of standardized data for individuals with vitiligo enrolled in clinical trials and…”
Get full text

Five year experience in management of perforated peptic ulcer and validation of common mortality risk prediction models – Are existing models sufficient? A retrospective cohort study by Anbalakan, K, Chua, D, Pandya, G.J, Shelat, V.G

“…Abstract Background Emergency surgery for perforated peptic ulcer (PPU) is associated with significant morbidity and mortality. Accurate and early risk…”
Get full text

Successful mentoring of women by Vasquez, Rebecca, Pandya, Amit G.

Get full text

Protection by taurine and thiotaurine against biochemical and cellular alterations induced by diabetes in a rat model by Budhram, Roshil, Pandya, Kashyap G, Lau-Cam, Cesar A

“…In this study, the actions of taurine (TAU), a sulfonate, and thiotaurine (TTAU), a thiosulfonate, on diabetes-mediated biochemical alterations in red blood…”
Get more information

A survey study of self‐reported comorbidities among adults with vitiligo in the United States by Ezzedine, Khaled, Anastassopoulos, Kathryn P., Gandhi, Kavita, Daniel, Shoshana R., Yamaguchi, Yuji, Sikirica, Vanja, Pandya, Amit G.

“…Background Vitiligo is an autoimmune disorder in which the immune system targets melanocytes, manifesting in patches of lost skin pigmentation. Objectives To…”
Get full text